Co-Authors
This is a "connection" page, showing publications co-authored by Daniel Wrapp and Jason McLellan.
Connection Strength
5.063
-
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Cell. 2020 06 11; 181(6):1436-1441.
Score: 0.887
-
Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies. Cell. 2020 05 28; 181(5):1004-1015.e15.
Score: 0.880
-
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020 03 13; 367(6483):1260-1263.
Score: 0.868
-
The 3.1-Angstrom Cryo-electron Microscopy Structure of the Porcine Epidemic Diarrhea Virus Spike Protein in the Prefusion Conformation. J Virol. 2019 12 01; 93(23).
Score: 0.852
-
Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science. 2020 09 18; 369(6510):1501-1505.
Score: 0.223
-
Iterative screen optimization maximizes the efficiency of macromolecular crystallization. Acta Crystallogr F Struct Biol Commun. 2019 Feb 01; 75(Pt 2):123-131.
Score: 0.201
-
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc Natl Acad Sci U S A. 2017 08 29; 114(35):E7348-E7357.
Score: 0.182
-
Author Correction: Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape. Nat Commun. 2021 Jul 01; 12(1):4177.
Score: 0.060
-
Cross-reactive coronavirus antibodies with diverse epitope specificities and Fc effector functions. Cell Rep Med. 2021 06 15; 2(6):100313.
Score: 0.059
-
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci Transl Med. 2021 05 12; 13(593).
Score: 0.059
-
Prolonged evolution of the human B cell response to SARS-CoV-2 infection. Sci Immunol. 2021 02 23; 6(56).
Score: 0.058
-
Local computational methods to improve the interpretability and analysis of cryo-EM maps. Nat Commun. 2021 02 23; 12(1):1240.
Score: 0.058
-
Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science. 2021 02 19; 371(6531):823-829.
Score: 0.058
-
Molecular determinants and mechanism for antibody cocktail preventing SARS-CoV-2 escape. Nat Commun. 2021 01 20; 12(1):469.
Score: 0.058
-
Continuous flexibility analysis of SARS-CoV-2 spike prefusion structures. IUCrJ. 2020 Sep 29; 7(Pt 6).
Score: 0.057
-
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness. Nature. 2020 10; 586(7830):567-571.
Score: 0.056
-
Broad neutralization of SARS-related viruses by human monoclonal antibodies. Science. 2020 08 07; 369(6504):731-736.
Score: 0.055
-
Immunogenicity of a DNA vaccine candidate for COVID-19. Nat Commun. 2020 05 20; 11(1):2601.
Score: 0.055
-
Site-specific glycan analysis of the SARS-CoV-2 spike. Science. 2020 07 17; 369(6501):330-333.
Score: 0.055
-
Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Sci Rep. 2018 Dec 10; 8(1):17823.
Score: 0.050
-
Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis. Sci Rep. 2018 10 24; 8(1):15701.
Score: 0.049
-
Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation. Immunity. 2018 02 20; 48(2):339-349.e5.
Score: 0.047
-
Corrigendum: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nat Commun. 2017 11 29; 8:16165.
Score: 0.046
-
A highly potent extended half-life antibody as a potential RSV vaccine surrogate for all infants. Sci Transl Med. 2017 05 03; 9(388).
Score: 0.045
-
Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. Nat Commun. 2017 02 13; 8:14158.
Score: 0.044